Response to: 'Comment on 'Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis' by Kuwabara ' by Rios Rodriguez .
作者信息
Tanimura Shun, Nakamura Hiroyuki, Horita Tetsuya
机构信息
Internal Medicine, Tomakomai City Hospital, Tomakomai, Hokkaido 053-8567, Japan.
Internal Medicine, Tomakomai City Hospital, Tomakomai, Hokkaido 053-8567, Japan
出版信息
Ann Rheum Dis. 2022 Jun;81(6):e94. doi: 10.1136/annrheumdis-2020-218055. Epub 2020 Jun 24.
Abstract
摘要
相似文献
1
Response to: 'Comment on 'Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis' by Kuwabara ' by Rios Rodriguez .对里奥斯·罗德里格斯所著《对桑原“关于托法替布成功治疗一名难治性大动脉炎合并溃疡性结肠炎患者的评论”的评论》的回应
Ann Rheum Dis. 2022 Jun;81(6):e94. doi: 10.1136/annrheumdis-2020-218055. Epub 2020 Jun 24.
2
Comment on 'Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis' by Kuwabara .对桑原发表的《托法替布成功治疗一名合并溃疡性结肠炎的难治性大动脉炎患者实现缓解》的评论
Ann Rheum Dis. 2022 Jun;81(6):e93. doi: 10.1136/annrheumdis-2020-217894. Epub 2020 Jun 24.
3
Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis.托法替布成功缓解一名合并溃疡性结肠炎的难治性大动脉炎患者的病情。
Ann Rheum Dis. 2020 Aug;79(8):1125-1126. doi: 10.1136/annrheumdis-2019-216606. Epub 2020 Mar 25.
4
A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib.一例大动脉炎合并难治性溃疡性结肠炎患者经托法替布治疗成功
Rheumatology (Oxford). 2020 Jul 1;59(7):1773-1775. doi: 10.1093/rheumatology/kez580.
5
JAK inhibitors as promising agents for refractory Takayasu arteritis.JAK抑制剂有望成为治疗难治性大动脉炎的药物。
Ann Rheum Dis. 2022 Apr;81(4):e67. doi: 10.1136/annrheumdis-2020-217577. Epub 2020 Apr 27.
6
Response to: 'JAK inhibitors as promising agents for refractory Takayasu arteritis' by Watanabe.对渡边所著《JAK抑制剂有望成为难治性大动脉炎的治疗药物》的回应。
Ann Rheum Dis. 2022 Apr;81(4):e68. doi: 10.1136/annrheumdis-2020-217680. Epub 2020 May 7.
7
Tofacitinib for the treatment of refractory Takayasu's arteritis: description of 2 cases.托法替布治疗难治性大动脉炎：2例病例描述
Clin Exp Rheumatol. 2020 Mar-Apr;38 Suppl 124(2):234-235. Epub 2020 Jan 9.
8
Improvements in PET/CT results and serum cytokine profile of HLA-B52-positive patients with Takayasu's arteritis and ulcerative colitis post-tofacitinib.托法替布治疗后，HLA - B52阳性的大动脉炎和溃疡性结肠炎患者PET/CT结果及血清细胞因子谱的改善情况。
Clin Exp Rheumatol. 2022 May;40(4):849-850. doi: 10.55563/clinexprheumatol/i9chku. Epub 2021 Jun 22.
9
Tofacitinib in patients with refractory Takayasu's arteritis.托法替布用于难治性大动脉炎患者。
Rheumatology (Oxford). 2020 Nov 1;59(11):e95-e98. doi: 10.1093/rheumatology/keaa281.
10
Takayasu's arteritis and ulcerative colitis.高安动脉炎与溃疡性结肠炎。
N Z Med J. 2003 Mar 14;116(1170):U359.
Zotero 插件